In:
The Journal of ECT, Ovid Technologies (Wolters Kluwer Health), Vol. 37, No. 2 ( 2021-6), p. 100-106
Abstract:
Electroconvulsive therapy (ECT) is controversial in children and adolescents (C/A). The primary objective of this study was to evaluate baseline characteristics of C/A in the utilization of ECT compared with the non-ECT group with the same primary indication. The secondary objective was to assess the trends in ECT utilization over 16 years and explore the predictors of length of stay. Methods Using the Nationwide Inpatient Sample database from the years 2002 to 2017, we identified patients (age ≤18 years) undergoing ECT in the United States using International Classification of Diseases, Ninth Revision and Tenth Revision, Clinical Modification/Procedure Coding System codes and compared with non-ECT C/A patients with the same primary diagnosis. Baseline clinical characteristics were assessed using descriptive analysis methods. Multilevel regression analysis and trend analysis were performed. Results Children and adolescent patients (n = 159,158) receiving (ECT: n = 1870) were more likely to be men (43.3% vs 36.7%) and of White race (58% vs 49%) ( P 〈 0.001). The hospital stay was longer (19 days vs 6 days, P 〈 0.001) for the ECT group than controls. ECT receiving C/A patients were more likely to have private insurance (72% vs 42%, P 〈 0.001). African American patients undergoing ECT treatment increased in number over the course of years (2002 to 2017), whereas the privately insured C/A patients receiving ECT decreased over the same period ( P 〈 0.001). There was an upward trend in ECT utilization for small bed size hospitals ( P 〈 0.001). Length of stay for C/A receiving ECT was longer for males ( P 〈 0.001) and patients with nonprivate insurance (p: 0.003). Conclusions Electroconvulsive therapy is not optimally used in C/A; therefore, formulated treatment guidelines are required.
Type of Medium:
Online Resource
ISSN:
1533-4112
,
1095-0680
DOI:
10.1097/YCT.0000000000000750
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2021
detail.hit.zdb_id:
2071131-1
Permalink